Osteoblast-derived survival factors protect PC-3 human prostate cancer cells from adriamycin apoptosis
- 1 August 1998
- Vol. 52 (2) , 341-347
- https://doi.org/10.1016/s0090-4295(98)00182-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Stimulation of human prostate cancer cell lines by factors present in human osteoblast‐like cells but not in bone marrowThe Prostate, 1995
- Mediation of glucocorticoid receptor function by the activation of latent transforming growth factor beta 1 in MG‐63 human osteosarcoma cellsInternational Journal of Cancer, 1995
- Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate CancerNew England Journal of Medicine, 1995
- Skeletal metastases in advanced prostate cancer: cell biology and therapyCritical Reviews in Oncology/Hematology, 1995
- Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancerJournal of Bone and Mineral Research, 1994
- Features of apoptotic cells measured by flow cytometryCytometry, 1992
- “Thymineless” death in androgen-independent prostatic cancer cellsBiochemical and Biophysical Research Communications, 1989
- Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow.Journal of Clinical Investigation, 1989
- Effects of human prostatic mitogens on rat bone cells and fibroblastsJournal of Endocrinology, 1987
- Selective osteoblast mitogens can be extracted from prostatic tissueThe Prostate, 1986